Related Experiment Video
Updated: Jul 6, 2026
08:35
Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
Published on: December 29, 2014
An institutional study on thymomas and thymic carcinomas: experience in 77 patients
1Department of Pathology, University of Heidelberg, Amalienstrasse 5, Heidelberg, Germany.
The Thoracic and Cardiovascular Surgeon
|March 28, 2008
Summary
Complete resection of thymomas and thymic carcinomas improves survival, but relapse remains a concern. Advanced tumor stage and histology significantly impact disease-free survival, necessitating new therapeutic strategies.
Area of Science:
- Oncology
- Thoracic Surgery
- Pathology
Background:
- Thymomas and thymic carcinomas are rare anterior mediastinal tumors.
- WHO classification (1999, updated 2004) and Masaoka staging are prognostically significant.
- Retrospective studies highlight the importance of classification, staging, and surgical extent.
Purpose of the Study:
- To evaluate prognostic factors for thymomas and thymic carcinomas.
- To assess the impact of surgical resection extent on patient outcomes.
- To identify areas for improved therapeutic strategies.
Main Methods:
- Retrospective analysis of 77 patients (1983-2000) with thymomas/thymic carcinomas.
- Focus on complete versus incomplete surgical resection.
- Median follow-up of 72.6 months.
Main Results:
- Overall 5-year survival was 71.4%.
- Histology and extent of resection were key survival factors.
- Incomplete resection led to a 5-year survival of only 29% despite adjuvant therapy.
- Tumor stage and histology were critical for disease-free survival in completely resected cases.
Conclusions:
- Complete resection offers encouraging therapeutic options for thymomas and thymic carcinomas.
- Type B2/B3 thymomas and thymic carcinomas show poorer outcomes.
- Incomplete surgical resection is associated with persistently poor outcomes, emphasizing the need for novel treatments.
